This is because GLP-1 medications appetite-suppressing hormonal effects reverse within weeks of stopping
(UADA photo)
She is board-certified in general pediatrics and board-eligible in pediatric endocrinology, with specialized expertise in caring for children and adolescents with obesity, insulin resistance, PMOS (formerly PCOS), prediabetes, Type 2 diabetes, and other complex metabolic conditions
Researchers designing GH axis studies, visceral fat metabolism protocols, or body composition research have both compounds verified to the same quality standard in a single order
However, as shown below, Zepbound demonstrated a notably greater mean percentage reduction in body weight, approximately 21%, compared to 11.2% to 14.9% for the others